Search research articles
Contact Us
Filters
Showing results (841-850 of 984) with videos related to
Page
of 99
Sort By:
Journal of Dentistry
|
June 13, 2009
Does gender and experience influence shade matching quality?
Helene J Haddad, Holger A Jakstat, Gerwin Arnetzl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 20, 2023
Amino Acids Fueling Fibroblast-Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration
Thomas Karonitsch, Victoria Saferding, Markus Kieler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 11, 2016
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses
Marjan Cruijsen, Willemijn Hobo, Walter J F M van der Velden, et al.
Pain Physician
|
December 3, 2025
Is Fibromyalgia a Nociplastic or a Mixed-pain Condition? International, Multidisciplinary Recommendations for Pain Phenotyping in Fibromyalgia Syndrome
Ismail Saracoglu, Randy Neblett, Esra Akin, et al.
Blood
|
November 16, 2017
Decitabine enhances targeting of AML cells by CD34<sup>+</sup> progenitor-derived NK cells in NOD/SCID/IL2Rg<sup>null</sup> mice
Jeannette Cany, Mieke W H Roeven, Janneke S Hoogstad-van Evert, et al.
Scientific Reports
|
December 11, 2014
A thin-film microprocessor with inkjet print-programmable memory
Kris Myny, Steve Smout, Maarten Rockelé, et al.
Cell Death & Disease
|
February 18, 2025
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia
Lisa Scheiblecker, Thorsten Klampfl, Eszter Doma, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional Chemotherapy
Jacobien R Hilberink, Linde M Morsink, Walter J F M van der Velden, et al.
Blood
|
June 22, 2011
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial
Evelien Kneppers, Bronno van der Holt, Marie-Jose Kersten, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2010
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program
Evelien Kneppers, Henk M Lokhorst, Corien M Eeltink, et al.
Page
of 99
Search research articles
Search
Showing results (841-850 of 984) with videos related to
Sort By:
Page
of 99
Journal of Dentistry
|
June 13, 2009
Does gender and experience influence shade matching quality?
Helene J Haddad, Holger A Jakstat, Gerwin Arnetzl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 20, 2023
Amino Acids Fueling Fibroblast-Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration
Thomas Karonitsch, Victoria Saferding, Markus Kieler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 11, 2016
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses
Marjan Cruijsen, Willemijn Hobo, Walter J F M van der Velden, et al.
Pain Physician
|
December 3, 2025
Is Fibromyalgia a Nociplastic or a Mixed-pain Condition? International, Multidisciplinary Recommendations for Pain Phenotyping in Fibromyalgia Syndrome
Ismail Saracoglu, Randy Neblett, Esra Akin, et al.
Blood
|
November 16, 2017
Decitabine enhances targeting of AML cells by CD34<sup>+</sup> progenitor-derived NK cells in NOD/SCID/IL2Rg<sup>null</sup> mice
Jeannette Cany, Mieke W H Roeven, Janneke S Hoogstad-van Evert, et al.
Scientific Reports
|
December 11, 2014
A thin-film microprocessor with inkjet print-programmable memory
Kris Myny, Steve Smout, Maarten Rockelé, et al.
Cell Death & Disease
|
February 18, 2025
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia
Lisa Scheiblecker, Thorsten Klampfl, Eszter Doma, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional Chemotherapy
Jacobien R Hilberink, Linde M Morsink, Walter J F M van der Velden, et al.
Blood
|
June 22, 2011
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial
Evelien Kneppers, Bronno van der Holt, Marie-Jose Kersten, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2010
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program
Evelien Kneppers, Henk M Lokhorst, Corien M Eeltink, et al.
Page
of 99